# Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/combination-of-lenvatinib-and-pembrolizumab-is-an-effective-treatment-option-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Christine Dierks,Jochen Seufert,Konrad Aumann,Juri Ruf,Claudius Klein,Selina Kiefer,Michael Rassner,Melanie Boerries,A. Zielke,Paul La Rosée,Philipp T. Meyer,Matthias Kroiß,Christian Weißenberger,Tilmann Schumacher,Patrick Metzger,Harald Weiss,Constantin Smaxwil,Katharina Laubner,Justus Duyster,Nikolas von Bubnoff,Cornelius Miething,Oliver Thomusch |
| Citations | 251 |
| DOI | 10.1089/thy.2020.0322 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1089/thy.2020.0322 |
| OpenAlex ID | https://openalex.org/W3124581135 |
| PMID | 33509020 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Jochen Seufert](https://scholariq.org/researchers/jochen-seufert/)

## Paper journal

- [Thyroid](https://scholariq.org/journals/thyroid/)

## Paper primary topic

- [Thyroid Cancer Diagnosis and Treatment](https://scholariq.org/topics/thyroid-cancer-diagnosis-and-treatment/)

## Paper topics

- [Thyroid Cancer Diagnosis and Treatment](https://scholariq.org/topics/thyroid-cancer-diagnosis-and-treatment/)
- [Cancer-related Molecular Pathways](https://scholariq.org/topics/cancer-related-molecular-pathways/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.